This $800,000 federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), will support research at Beth Israel Deaconess Medical Center, Inc. (Bidmc) to develop new combinatorial pharmacology approaches for regulating multiple neuron types in the brain to effectively promote satiety and reduce body weight in mouse models of obesity. The research aims to...
This $578,060 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), aims to study a potential new enhancer region that activates the UCP1 gene, which is critical for thermogenesis and energy expenditure. The research will examine how this enhancer functions to increase UCP1 transcription, as well as assess its impact on thermogenesis, adiposity, and...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $250,000 Cooperative Agreement titled "METABOLOMICS WORKBENCH - NATIONAL METABOLOMICS DATA REPOSITORY" to the University of California, San Diego (UCSD). This award, under CFDA Program 93.847 "Diabetes, Digestive, and Kidney Diseases Extramural Research", will fund the continuation and enhancement of the Metabolomics Workbench - National Metabolomics Data Repository (MW-NMDR). The MW-NMDR...
This Project Grant awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) will fund a $506,598.00 research project at the Harvard T.H. Chan School of Public Health from September 15, 2024 to August 31, 2025. The project aims to determine the effects of dietary fat and carbohydrate composition on fundamental energy metabolism processes, including tissue fuel selection,...
This $224,088 federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) will fund research to investigate the physiological regulation of energy intake during meals following weight loss. The award recipient, the University of Colorado-Denver, will analyze energy balance and gut hormone data from the ARROW and TIME2EAT studies to examine the role of gut...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the CFDA program "Diabetes, Digestive, and Kidney Diseases Extramural Research" (93.847), will provide $340,175 to American University to conduct research on the effects of federal funding for obesity prevention programs on weight-related health behaviors, obesity prevalence, and obesity-related chronic conditions. The project aims to leverage variation in county and...
This federal Project Grant award, valued at $748,625.76, was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant was awarded to The Regents of the University of California, San Francisco on Aug 2, 2024, with a final completion date of Jul 31, 2027. The funding supports a research project focused on "Translational Regulation of PGC1alpha and Oxidative...
This federal Project Grant award in the amount of $640,762.00 was issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award, with a start date of September 15, 2024 and an ultimate completion date of June 30, 2029, will fund research conducted by the Scripps Research Institute in La Jolla, California to investigate the interorgan communication mechanisms between...
This federal Project Grant award, valued at $450,000.00 and awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), aims to elucidate the roles of the lysine acetyltransferase KAT8 in adipocyte function and its impact on lipoatrophy and systemic insulin resistance. The long-term objective is to understand how adipocyte KAT8 contributes to adipose tissue function and...
This $1,089,491 Project Grant awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) will fund a research project led by the University of California, Los Angeles (UCLA) from March 2025 through February 2029. The project aims to develop novel statistical methods, computational algorithms, and user-friendly software to study individual health trajectories and quantify...